Suppr超能文献

白蛋白和晚期糖基化终产物对近端肾小管细胞中乙酰肝素酶的调控

Regulation of heparanase by albumin and advanced glycation end products in proximal tubular cells.

作者信息

Masola Valentina, Gambaro Giovanni, Tibaldi Elena, Onisto Maurizio, Abaterusso Cataldo, Lupo Antonio

机构信息

Department of Experimental Biomedical Sciences, University of Padova, Padova, Italy.

出版信息

Biochim Biophys Acta. 2011 Aug;1813(8):1475-82. doi: 10.1016/j.bbamcr.2011.05.004. Epub 2011 May 12.

Abstract

Diabetic nephropathy is one of the main causes of end-stage renal disease, in which the development of tubular damage depends on factors such as high glucose levels, albuminuria and advanced glycation end-product. In this study, we analyzed the involvement of heparanase, a heparan sulfate glycosidase, in the homeostasis of proximal tubular epithelial cells in the diabetic milieu. In vitro studies were performed on a wild-type and stably heparanase-silenced adult tubular line (HK2) and HEK293. Gene and protein expression analyses were performed in the presence and absence of diabetic mediators. Albumin and advanced glycation end-product, but not high glucose levels, increased heparanase expression in adult tubular cells via the AKT/PI3K signaling pathway. This over-expression of heparanase is then responsible for heparan sulfate reduction via its endoglycosidase activity and its capacity to regulate the heparan sulfate-proteoglycans core protein. In fact, heparanase regulates the gene expression of syndecan-1, the most abundant heparan sulfate-proteoglycans in tubular cells. We showed that heparanase is a target gene of the diabetic nephropathy mediators albumin and advanced glycation end-product, so it may be relevant to the progression of diabetic nephropathy. It could take part in several processes, e.g. extracellular-matrix remodeling and cell-cell crosstalk, via its heparan sulfate endoglycosidase activity and capacity to regulate the expression of the heparan sulfate-proteoglycan syndecan-1.

摘要

糖尿病肾病是终末期肾病的主要病因之一,其中肾小管损伤的发展取决于高血糖水平、蛋白尿和晚期糖基化终产物等因素。在本研究中,我们分析了乙酰肝素酶(一种硫酸乙酰肝素糖苷酶)在糖尿病环境中近端肾小管上皮细胞内稳态中的作用。对野生型和稳定沉默乙酰肝素酶的成年肾小管细胞系(HK2)以及HEK293进行了体外研究。在有和没有糖尿病介质的情况下进行基因和蛋白质表达分析。白蛋白和晚期糖基化终产物而非高血糖水平,通过AKT/PI3K信号通路增加成年肾小管细胞中乙酰肝素酶的表达。乙酰肝素酶的这种过表达随后通过其内切糖苷酶活性及其调节硫酸乙酰肝素蛋白聚糖核心蛋白的能力导致硫酸乙酰肝素减少。事实上,乙酰肝素酶调节了Syndecan-1的基因表达,Syndecan-1是肾小管细胞中最丰富的硫酸乙酰肝素蛋白聚糖。我们表明,乙酰肝素酶是糖尿病肾病介质白蛋白和晚期糖基化终产物的靶基因,因此它可能与糖尿病肾病的进展相关。它可能通过其硫酸乙酰肝素内切糖苷酶活性以及调节硫酸乙酰肝素蛋白聚糖Syndecan-1表达的能力参与多个过程,例如细胞外基质重塑和细胞间串扰。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验